Aceragen | 영업 이익



Operating Profit 변화 날짜
Abbott USD 1.66B 253M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Cipla INR 12.29B 4.8B 2025-03
Clal Biotechnology ILS -1738000 7.46M 2022-12
Compugen USD -7483000 11.98M 2024-12
CSL USD 1.98B 778M 2024-12
Dynavax Technologies USD -23630000 22M 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Grifols EUR 371.86M 54.83M 2024-12
Merck USD 5.87B 1.57B 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
X T L Biopharmaceuticals USD -812000 48K 2024-12



Aceragen 영업 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Jul 2025.